Premier Opioid Resources/Research

• Top ten strategies for hospitals to prevent opioid-related adverse events, 2017download .docx file
• Opioid epidemic facts: use-misuse-diversion, 2017download .docx file

• NQP Playbook™: Opioid Stewardship opens in a new tab– Premier is a proud member of the National Quality Partnership (NQP) Stewardship Action Team that developed this guide of best practices and strategies for effective pain management and opioid stewardship.
• Premier’s capabilities for opioid stewardship PDF opens in a new tab– experts, technology and resources aligned with the seven fundamentals of the NQF Playbook: Opioid Stewardship.

• Modernize Health Information Laws to tackle opioid crisis. Premier is leading the lobbying activities of the Coalition of 39 national organizations (www.helpendopioidcrisis.orgopens in a new tab)pushing legislation (H.R. 3545 / S. 1850) to insert HIPAA’s treatment, payment and healthcare operations policy into 42 CFR Part 2. The goal is to modernize health information la to enable the sharing of a patient’s entire medical record, including addiction records, so providers have a the information necessary to provide safe, effective, high quality treatment and care.
• Premier has engaged with the White House and the President’s Opioid Task Force on importance of amending the 1972 addiction privacy to enable care coordination. Premier efforts in tandem with the Coalition resulted in the President’s Opioid Task Force recommending that Congress pass H.R. 3545 / S.1850 as one of 56 recommendations to tackle the opioid crisis impacting the country as a whole.
• House passed Premier-supported Overdose Prevention and Patient Safety Act (H.R. 6082) on June 20, 2018 opens in a new tab. Premier’s efforts resulted in passage of this Act that paves the way to modernize a 40-year old law that has impeded healthcare providers’ ability to diagnose, treat and prevent addiction and other opioid-related disorders.
• Premier’s response to the House Ways and Means Committeedownload PDF, opens in a new tab on ways to address the opioid crisis (3.15.18)
• More information on Premier Public Affairs effortsopens in a new tab

• An annotated searchable repository of all Premier group purchasing contracts, suppliers, services and programs in the pain management space. Premier members can access this resource through its integrated intelligence platform PremierConnect® This toolkit supports efforts to improve prescribing practices, opioid use and patient safety through alternative methods and medications. Premier members can search for alternative therapies, as well as devices that monitor oxygen and carbon dioxide levels to avoid respiratory-related side effects, and treatments to improve the immune system’s response to opioids.
• Premier Safer Pain Management Product Portfolio – Sign in opens in a new tab
  (GPO Members only; log in required)

This report is an analysis to assess the need to institute new (or reinforce existing) improvement efforts in the management of patients presenting to the ED with an opioid OD using Premier’s Quality Advisor comparative database (details below). Analysis includes patients treated and released and admitted for inpatient care.

Sign in to view Premier’s Opioid Overdoses (ODs) Treated in the Emergency Department (ED), 2018 opens in a new tab

Report Highlights/Key Data Elements

• Opioid OD Treatment Rate Comparison
• Cost of Care for Opioid ODs Treated in the ED
• Opioid ODs: Treated and Released vs. Treated and Admitted Cases
• What Can Be Done: Improvement Strategies and Resources

Sign in to view Premier Data Optimization Report: Opioids Use in the Emergency Department 2017
(QualityAdvisorTM subscribers only).opens in a new tab

An analysis of opioid visits, utilization, and prescribing practices in the emergency department using Premier’s Quality Advisor comparative database:

• Report Highlights: The population for the Opioid Use in the Emergency Department (ED) includes patients treated and released from the ED. The analysis did not include those ED patients admitted and those who did not receive an opioid
  during their ED visit, but left the ED with a prescription for an opioid.
• Key data elements:
  • Overall ED opioid utilization rate
  • Frequency of ED visits with opioid use
  • Opioid utilization by drug and formulation (short-acting or extended release)
  • Opioid use by diagnosis for treated and released ED patients receiving opioids
• Source of data for report: Premier Quality Advisor™
  The Premier Quality Advisor™ Platform opens in a new tab contains data on 40 percent of all U.S. inpatient hospital discharges. This comparative database measures and analyzes performance to improve patient outcomes and reduce costs by integration of quality, safety and financial data. This is accomplished through benchmarking clinical and financial outcomes against peer hospitals; comparing internal and external performances in shaping best decisions identifying care practice variations; reducing mortality, complications, readmissions and hospital-associated conditions; monitoring ongoing efforts to improve quality, resource utilization, and efficiency; and complying with regulatory reporting requirements.
• For more information about Quality Advisor, please call the Informatics Solution Center at: 800.805.4608.

​Clinical and medication surveillance solutions that provide real-time alerts on high-risk drugs and potentially dangerous drug combination interactions, as well as monitors patients prescribed high-dose long acting/extended release opioids. These solutions include recommendations for co-prescribing naloxone and educational tools for patient and family naloxone use prior to discharge.

Vist Theradoc^® for more information.opens in a new window

Publications on opioid-related outcomes and economics conducted by Premier Applied Sciences opens in a new window

Articles

• Oderda GM, Gan TJ, Johnson BH, Robinson SB. Effect of opioid-related adverse events on outcomes in selected surgical patients.  J Pain Palliative Care Pharmacother.opens in a new window 2013 Mar;27(1):62-70. doi: 10.3109/15360288.2012.751956. Epub 2013 Jan 9.
• Gan TJ, Robinson SB, Oderda GM, Scranton R, Pepin J, Ramamoorthy S. Impact of postsurgical opioid use and ileus on economic outcomes in gastrointestinal surgeries. Curr Med Res Opin. 2015 opens in a new tab Apr;31(4):677-86. doi: 10.1185/03007995.2015.1005833. Epub 2015 Feb 10.
• Lasky T, Ernst F, Greenspan J, Wang S, Gonzalez G. Estimating pediatric inpatient medication use in United States. Pharmacoepidemiology Drug Safety 2010opens in a new window
• Lasky T, Greenspan J, Ernst FR, Gonzalez L. Morphine use in hospitalized children in the United States: A descriptive analysis of data from pediatric hospitalizations in 2008. Clin Ther. 2012 Mar;34(3):720-7 opens in a new tab.
• Article: Ernst FR, Mills JR, Berner T, House J. Opioid medication practices in chronic pain patients presenting for all-causes to emergency department: Prevalence and impact on health outcomes. J Manag Care Spec Pharm 2015;21(10):925-36 opens in a new tab
• Herzig, S. J., Rothberg, M. B., Cheung, M., Ngo, L. H., & Marcantonio, E. R. (February 13, 2014). Opioid utilization and opioid-related adverse events in nonsurgical patients in US hospitals. Journal of Hospital Medicine, 9, 2, 73-81opens in a new window

Abstracts Presented

• Abstract: Schechter LN, Harshaw Q, Frye CB, Ernst FR, Krukas MR, Shillington AC. Costs Associated with Intravenous Patient Controlled Analgesia (IV PCA) in US PDF opens in a new tab.
  Presented at International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 2013
• Abstract: Miller TE, Ernst FR, Krukas MR Gan TJ. Level of compliance with the enhanced recovery after surgery (ERAS) protocol and postoperative outcomesPDF opens in a new tab .
  Presented at International Anesthesia Research Society (IARS) 2013
• Abstract: Gan TJ, Oderda GM Robinson SB. Opioid-related adverse events increase length of stay and drive up total cost of care in a national database of post surgical patientsPDF opens in a new tab.
  Presented at International Anesthesia Research Society (IARS) 2012
• Abstract: Oderda GM, Robinson SB, Tong GJ et al. Impact of post-surgical opioid use and ileus on economic outcomes in gastrointestinal surgeriesPDF opens in a new tab.
  Presented at International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 2012)
• Abstract: Gan TJ, Robinson SB, and Oderda GM. Impact of Postsurgical Opioid Use and Adverse Drug Events on Economic Outcomes in Hysterectomy Surgeries. Presented at Society for Ambulatory
  Anesthesia (SAMBA) 2012PDF opens in a new tab
• Abstract: Ramamoorthya S, Robinson SB. Impact of opioid related adverse events on length of stay and hospital costs in patients a laparoscopic colectomy. PDF opens in a new tab Presented
  at Digestive Disease Week (DDW) 2012

Advisor Live

• Advisor Live: Safe Opioid Use – Strategies for reducing adverse events and related harm
  • Slides opens in a new window
  • Audio presentation opens in a new window

Premier PFP, QUEST ADE and Harm Collaborative

• Reducing ADEs and harm associated with opioids – Safer post-operative pain management
• Contemporary Pain Management: T.J. Gan M.D. Slidesdownload PDF in new tab